iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
Go back to iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication| (NASDAQ: IMDX) | Delayed: 4.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.13 | 52 Week High | $ | |||
| Open | $4.13 | 52 Week Low | $ | |||
| Day High | $4.13 | P/E | N/A | |||
| Day Low | $4.13 | EPS | $ | |||
| Volume | 1,662 | |||||

